Cardiovascular, bleeding, and mortality risks in elderly Medicare patients treated with dabigatran or warfarin for nonvalvular atrial fibrillation
…, M Houstoun, TE MaCurdy, C Worrall, JA Kelman - Circulation, 2015 - Am Heart Assoc
Background— The comparative safety of dabigatran versus warfarin for treatment of
nonvalvular atrial fibrillation in general practice settings has not been established. Methods and …
nonvalvular atrial fibrillation in general practice settings has not been established. Methods and …
Risk of acute myocardial infarction, stroke, heart failure, and death in elderly Medicare patients treated with rosiglitazone or pioglitazone
…, TE MaCurdy, F Ali, C Sholley, C Worrall, JA Kelman - Jama, 2010 - jamanetwork.com
Context Studies have suggested that the use of rosiglitazone may be associated with an
increased risk of serious cardiovascular events compared with other treatments for type 2 …
increased risk of serious cardiovascular events compared with other treatments for type 2 …
Stroke, bleeding, and mortality risks in elderly medicare beneficiaries treated with dabigatran or rivaroxaban for nonvalvular atrial fibrillation
…, TE MaCurdy, C Worrall, JA Kelman - JAMA internal …, 2016 - jamanetwork.com
Importance Dabigatran and rivaroxaban are non–vitamin K oral anticoagulants approved
for stroke prevention in patients with nonvalvular atrial fibrillation (AF). There are no …
for stroke prevention in patients with nonvalvular atrial fibrillation (AF). There are no …
Comparative risk of anaphylactic reactions associated with intravenous iron products
Importance All intravenous (IV) iron products are associated with anaphylaxis, but the
comparative safety of each product has not been well established. Objective To compare the risk …
comparative safety of each product has not been well established. Objective To compare the risk …
[HTML][HTML] Sepsis among medicare beneficiaries: 1. The burdens of sepsis, 2012–2018
…, RA Bright, TE MaCurdy, JA Kelman - Critical care …, 2020 - journals.lww.com
Objectives: To provide contemporary estimates of the burdens (costs and mortality) associated
with acute inpatient Medicare beneficiary admissions for sepsis. Design: Analysis of paid …
with acute inpatient Medicare beneficiary admissions for sepsis. Design: Analysis of paid …
Comparative stroke, bleeding, and mortality risks in older medicare patients treated with oral anticoagulants for nonvalvular atrial fibrillation
…, MR Southworth, TE MaCurdy, JA Kelman - The American Journal of …, 2019 - Elsevier
Background Nonvitamin K antagonist oral anticoagulants (NOACs) are alternatives to warfarin
in patients with nonvalvular atrial fibrillation. Randomized trials compared NOACs with …
in patients with nonvalvular atrial fibrillation. Randomized trials compared NOACs with …
Bronchoalveolar lavage in interstitial lung disease
SE WEINBERGER, JA KELMAN… - Annals of internal …, 1978 - acpjournals.org
Cellular and immunoglobulin components of bronchoalveolar fluid recovered by bronchoscopic
lavage were evaluated in 32 control patients, 10 normal volunteers, and 60 patients with …
lavage were evaluated in 32 control patients, 10 normal volunteers, and 60 patients with …
Collagenase in the lower respiratory tract of patients with idiopathic pulmonary fibrosis
JE Gadek, JA Kelman, G Fells… - … England Journal of …, 1979 - Mass Medical Soc
To test the hypothesis that idiopathic pulmonary fibrosis (IPF) is mediated through collagenase
present in the lower respiratory tract, we used the fiberoptic bronchoscope to obtain fluid …
present in the lower respiratory tract, we used the fiberoptic bronchoscope to obtain fluid …
[HTML][HTML] Sepsis among medicare beneficiaries: 3. The methods, models, and forecasts of sepsis, 2012–2018
…, RA Bright, TE MaCurdy, JA Kelman - Critical care …, 2020 - journals.lww.com
Objective: To evaluate the impact of sepsis, age, and comorbidities on death following an
acute inpatient admission and to model and forecast inpatient and skilled nursing facility costs …
acute inpatient admission and to model and forecast inpatient and skilled nursing facility costs …
Mortality among Parkinson's disease patients treated with pimavanserin or atypical antipsychotics: an observational study in medicare beneficiaries
…, LM Nelson, TE MaCurdy, JA Kelman… - American Journal of …, 2022 - Am Psychiatric Assoc
Objective: Pimavanserin, a serotonin 5-HT 2 antagonist, is indicated for treatment of hallucinations
and delusions associated with Parkinson’s disease psychosis. In premarketing trials …
and delusions associated with Parkinson’s disease psychosis. In premarketing trials …